News

Researchers identify aggressive molecular features in low-risk prostate cancer

Europe now runs just one in five of the world’s cancer trials

FDA approves tucatinib with trastuzumab and pertuzumab for the maintenance treatment of HER2-positive breast cancer

Current age-based genetic testing in patients with cancer may miss majority of inherited gene variants

How does early gastric cancer arise? The key role of the spatial niche

Newly identified prostate cell type may help explain why enlarged prostate develops in one region of gland

Making paediatric cancer more ‘visible’ boosts immunotherapy response

Major HER2+ breast cancer trial identifies factors associated with pathologic complete response to less intensive chemotherapy

International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases

PSMA PET/CT-targeted biopsy improves detection of clinically significant prostate cancer

KRAS inhibition combined with CTLA-4 blockade overcomes immunotherapy resistance in KRAS-mutant gastric cancer

Chemo as a booster of cancer vaccines